Flea-borne typhus infections are on the rise in SoCal: How to protect yourself and your pets Jasmine, 11, receives an anti-flea vaccination at a free vaccine clinic in San Francisco.

The Federal Government has awarded a patent through Special License to the University of Jos for the institution’s groundbreaking invention of an Anti-Tick Vaccine (JUTVAC-NG). This monumental ...

Tired of predictable anime romances? This article highlights a selection of anti-romance anime that prioritize compelling narratives over forced love ...

The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older against fleas and ticks.

Bravecto Quantum, a long-acting injectable flea and tick treatment from Merck Animal Health, received Food and Drug Administration approval for dogs at least six months old.

Bravecto Quantum, a breakthrough, long-acting flea and tick treatment and preventative for dogs, will be available soon.

BRAVECTO QUANTUM is also indicated for the treatment and control of Amblyomma americanum (lone star tick) infestations for 8 months in dogs and puppies 6 months of age and older.

New treatment offers dogs year-round protection with a single shot.

FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.

FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.

Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in dogs.